|
Making Policy When The Evidence Is In Dispute
David Atkins,
Joanna Siegel and
Jean Slutsky
Policymakers often struggle with medical issues that are the subject of fierce scientific debate. On closer examination, many of these debates are manifestations of conflicting perspectives and values as much as disagreements over the evidence. We summarize common factors underlying recent debates and outline a series of questions that can help disentangle questions of evidence from those of values. These questions focus on identifying the most important outcomes, evaluating the quality of evidence, and assessing the trade-offs involved. We then use four recent policy debates—involving prostate-specific antigen (PSA) screening, high-dose chemotherapy for breast cancer, antibiotic therapy for otitis media, and newborn hearing screening—to illustrate how this approach can help clarify areas of agreement and disagreement of the opposing sides.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
D. B. Petitti, S. M. Teutsch, M. B. Barton, G. F. Sawaya, J. K. Ockene, T. DeWitt, and on behalf of the U.S. Preventive Services Task For
Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence
Ann Intern Med,
February 3, 2009;
150(3):
199 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Jacobson
Transforming Clinical Practice Guidelines Into Legislative Mandates: Proceed With Abundant Caution
JAMA,
January 9, 2008;
299(2):
208 - 210.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. I. Kaye and and the Committee on Genetics
Newborn Screening Fact Sheets
Pediatrics,
September 1, 2006;
118(3):
e934 - e963.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Neumann
Emerging Lessons From The Drug Effectiveness Review Project
Health Aff.,
July 1, 2006;
25(4):
W262 - W271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. R. Howell
We Need Expanded Newborn Screening
Pediatrics,
May 1, 2006;
117(5):
1800 - 1805.
[Full Text]
[PDF]
|
|
|
|
